Literature DB >> 9483719

Linearly divergent treatment effects in clinical trials with repeated measures: efficient analysis using summary statistics.

L J Frison1, S J Pocock.   

Abstract

In many randomized clinical trials with repeated measures of a response variable one anticipates a linear divergence over time in the difference between treatments. This paper explores how to make an efficient choice of analysis based on individual patient summary statistics. With the objective of estimating the mean rate of treatment divergence the simplest choice of summary statistic is the regression coefficient of response on time for each subject (SLOPE). The gains in statistical efficiency imposed by adjusting for the observed pre-treatment levels, or even better the estimated intercepts, are clarified. In the process, we develop the optimal linear summary statistic for any repeated measures design with assumed known covariance structure and shape of true mean treatment difference over time. Statistical power considerations are explored and an example from an asthma trial is used to illustrate the main points.

Entities:  

Mesh:

Year:  1997        PMID: 9483719     DOI: 10.1002/(sici)1097-0258(19971230)16:24<2855::aid-sim749>3.0.co;2-y

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  13 in total

1.  A modelling strategy for the analysis of clinical trials with partly missing longitudinal data.

Authors:  Ian R White; Erica Moodie; Simon G Thompson; Tim Croudace
Journal:  Int J Methods Psychiatr Res       Date:  2003       Impact factor: 4.035

2.  Rule-of-thumb adjustment of sample sizes to accommodate dropouts in a two-stage analysis of repeated measurements.

Authors:  John E Overall; Scott Tonidandel; Robert R Starbuck
Journal:  Int J Methods Psychiatr Res       Date:  2006       Impact factor: 4.035

3.  Adding Subjects or Adding Measurements in Repeated Measurement Studies Under Financial Constraints.

Authors:  Song Zhang; Chul Ahn
Journal:  Stat Biopharm Res       Date:  2011-02-01       Impact factor: 1.452

4.  Conservative Sample Size Determination for Repeated Measures Analysis of Covariance.

Authors:  Timothy M Morgan; L Douglas Case
Journal:  Ann Biom Biostat       Date:  2013-07-05

5.  Optimal combination of number of participants and number of repeated measurements in longitudinal studies with time-varying exposure.

Authors:  Jose Barrera-Gómez; Donna Spiegelman; Xavier Basagaña
Journal:  Stat Med       Date:  2013-06-05       Impact factor: 2.373

6.  Effect of calcium dobesilate on progression of early diabetic retinopathy: a randomised double-blind study.

Authors:  Maria L Ribeiro; Andras I Seres; Angela M Carneiro; Michael Stur; Alain Zourdani; Patricia Caillon; José G Cunha-Vaz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-12       Impact factor: 3.117

7.  Study design and methods for a randomized crossover trial substituting brown rice for white rice on diabetes risk factors in India.

Authors:  Nicole M Wedick; Vasudevan Sudha; Donna Spiegelman; Mookambika Ramya Bai; Vasanti S Malik; Siva Sankari Venkatachalam; Vijayalaksmi Parthasarathy; Ruchi Vaidya; Lakshmipriya Nagarajan; Kokila Arumugam; Clara Jones; Hannia Campos; Kamala Krishnaswamy; Walter Willett; Frank B Hu; Ranjit Mohan Anjana; Viswanathan Mohan
Journal:  Int J Food Sci Nutr       Date:  2015-05-28       Impact factor: 3.833

8.  Evaluation of vaccine-induced antibody responses: impact of new technologies.

Authors:  Daniel J Zaccaro; Diane K Wagener; Carol C Whisnant; Herman F Staats
Journal:  Vaccine       Date:  2013-04-11       Impact factor: 3.641

9.  Power and sample size calculations for longitudinal studies comparing rates of change with a time-varying exposure.

Authors:  X Basagaña; D Spiegelman
Journal:  Stat Med       Date:  2010-01-30       Impact factor: 2.373

10.  On summary measure analysis of linear trend repeated measures data: performance comparison with two competing methods.

Authors:  Mehrdad Vossoughi; S M T Ayatollahi; Mina Towhidi; Farzaneh Ketabchi
Journal:  BMC Med Res Methodol       Date:  2012-03-22       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.